Skip to content

Author

Liyan Miao

We have 5 of 21 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Association between anti-thymocyte globulin exposure and clinical outcomes of adult undergoing haploidentical hematopoietic stem cell transplantation with myeloablative conditioning: a pharmacokinetic-guided study.

BACKGROUND Rabbit antithymocyte globulin (rATG) plays a critical role in preventing graft-versus-host disease (GVHD) after haploidentical hematopoietic stem cell transplantation (haplo-HSCT). However, conventional weight-based dosing results in substantial interpatient variability in active rATG exposure, potentially a...

Rui Gao, Chen-Rong Huang, Xiao-Xue Liu et al. · 0 citations
Open access Oct 2026

Population cellular kinetics and exposure-CSR analysis of CAR-T cells in Chinese patients with relapsed/refractory B-ALL

Background CD19-targeting chimeric antigen receptor (CAR)-T cells have demonstrated great efficacy in treating relapsed and refractory B-cell acute lymphoblastic leukemia (B-ALL). Despite the high objective response rate of CAR-T cell therapy, high-risk adverse event of cytokine-release syndrome occur unexpectedly. Obj...

Yi-Cong Bian, Jin-Jie Yuan, Chen-Rong Huang et al. · 0 citations
#protein folding Open access Oct 2026

Longitudinal monitoring of adalimumab levels and anti-adalimumab antibodies in Chinese patients with ankylosing spondylitis: a prospective cohort study

This study aimed to clarify the association between longitudinal adalimumab concentrations, anti-adalimumab antibodies (AAA) levels, and clinical response in Chinese patients with ankylosing spondylitis (AS). A prospective multi-center, observational cohort study of AS patients receiving adalimumab therapy w...

Xiao-Liang Ding, Ling Xue, Ming-Jun Wang et al. · 0 citations
Open access Sep 2026

Patient-derived organoids enable ex vivo drug-response profiling for precision medicine in bladder cancer

Patient-derived organoids (PDOs) represent a promising precision medicine approach for replicating primary tumor characteristics and facilitating drug testing across various cancers, although clinical evidence in bladder cancer remains limited. This study evaluates the impact of incorporating PDOs into clinical pract...

Si-Jia Li, Feng Qiu, Fang-Yue Zheng et al. · 0 citations
Jul 2026

A UHPLC-MS/MS method for the simultaneous quantification of BTK inhibitors and their active metabolite in human plasma and cerebrospinal fluid.

This method detects four BTK-related analytes in plasma/CSF with a 3-min run time, evaluation of hemolytic/lipemic matrices, and clinical validation, increasing throughput, reducing costs, and broadening applicability, providing preliminary feasibility data for clinical TDM.

Sijia Li, Jiameng Xie, F. Xia et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.